ah.okwuosa
Submits third-party assay reports on material purchased directly. Based in Aarhus.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.21%
n=6
Suppliers covered
5
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042027 | Ipamorelin | TFC | TFC-2603-M6766 | VendorInvestigate | 2026-Q2 | 99.93 | 5.61 | 99.3 | Laboratory-retained | 0 | PASS |
| AX-2026-042878 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2509-T2530 | Janoshik | 2026-Q1 | 98.98 | 3.99 | — | Laboratory-retained | 1 | FAIL |
| AX-2025-020148 | CJC-1295 (no DAC) | GGPeps | GGPE-2507-D8658 | PeptideMeter | 2025-Q4 | 98.78 | 3.95 | 100.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019474 | PEG-MGF | Homopeptide | HOMO-2412-B9129 | Janoshik | 2025-Q2 | 98.47 | 4.94 | — | Supplier-supplied | 1 | FAIL |
| AX-2024-004463 | MOTS-c | FGP | FGP-2411-A1460 | Janoshik | 2024-Q4 | 99.66 | 5.74 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004538 | Semaglutide | JEEP | JEEP-2401-R2856 | Janoshik | 2024-Q2 | 99.43 | 8.30 | — | Supplier-supplied | 0 | FAIL |
| Supplier | Records | Median purity |
|---|---|---|
| GGPeps | 2 | n<3 |
| TFC | 1 | n<3 |
| Homopeptide | 1 | n<3 |
| FGP | 1 | n<3 |
| JEEP | 1 | n<3 |